In the news | 18th September 2015
IDBS takes Silicon Valley approach to global R&D software delivery
BioPharma Dive
September 2015
BioPharma Dive covers the recent appointment of our CTO, Peter Murray, and the deliberate shift IDBS is making to accelerate innovation and bring new products to the market.
More news
Proper data management is crucial for speeding up the process of discovering and developing drugs
Do you have a vision for clean, contextualized data? Is IT accountable to the bench in your lab? Are you willing to value even the most unassuming insights?
The key to painless data integrity for bioanalysis labs
Maintaining the balance between compliance and efficiency is what will set a CRO apart in the highly competitive outsourcing landscape and inspire the sponsor’s confidence.
Bringing data quality to the CRO-BioPharma partnership
Drug sponsors value – and rely on – the work that CROs perform. CROs have a chance to up their data management game. How can they ensure data quality?
New cell therapy guide highlights importance of Skyland PIMS
Learn the importance of enterprise control in getting CGTs to market – and the critical systems that enable this control in cell-based therapy manufacturing.